NASDAQ:CODX | Free Cash Flow | Co-Diagnostics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$7.85M$142,017.00-$7.99M
2025-12-31-$6.2M$131,969.00-$6.33M
2025-03-31-$8.75M$91,913.00-$8.84M
2024-12-31-$8.23M$72,987.00-$8.3M
2024-03-31-$8.49M$402,293.00-$8.89M
2023-12-31-$4.78M$464,602.00-$5.24M
2023-03-31-$5.92M$179,944.00-$6.1M
2022-12-31-$4.01M$293,304.00-$4.3M
2022-03-31$7.81M$396,600.00$7.41M63.25%
2021-12-31$4.88M$121,755.00$4.76M63.44%
2021-03-31$12.27M$139,558.00$12.13M153.57%
2020-12-31$19.96M$468,714.00$19.49M152.17%
2020-03-31-$1.34M$100,370.00-$1.44M
2019-12-31-$1.61M$36,220.00-$1.65M
2019-03-31-$1.37M
2018-12-31-$960,635.00$38,836.00-$999,471.00
2018-03-31-$968,524.00$9,688.00-$978,212.00
2017-12-31-$992,436.00$38,348.00-$1.03M
2017-03-31-$419,736.00$41,046.00-$460,782.00
2016-12-31-$555,896.00$4,741.00-$560,637.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$29.14M$700,047.00-$29.84M
2024-12-31-$29.16M$748,352.00-$29.9M
2023-12-31-$22.08M$1.37M-$23.45M
2022-12-31$6.57M$1.43M$5.14M
2021-12-31$41.08M$669,463.00$40.41M110.24%
2020-12-31$28.17M$774,397.00$27.39M64.48%
2019-12-31-$5.53M$113,246.00-$5.64M
2018-12-31-$4.08M$41,336.00-$4.12M
2017-12-31-$3.21M$129,306.00-$3.34M
2016-12-31-$1.31M$12,241.00-$1.32M